Pyronaridine: a review of its clinical pharmacology in the treatment of malaria

Pyronaridine-artesunate was recently strongly recommended in the 2022 update of the WHO Guidelines for the Treatment of Malaria, becoming the newest artemisinin-based combination therapy (ACT) for both uncomplicated Plasmodium falciparum and Plasmodium vivax malaria. Pyronaridine-artesunate, availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Wan-Yu, Dorlo, Thomas P C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545508/
https://www.ncbi.nlm.nih.gov/pubmed/37638690
http://dx.doi.org/10.1093/jac/dkad260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545508/
https://www.ncbi.nlm.nih.gov/pubmed/37638690
http://dx.doi.org/10.1093/jac/dkad260

Ejemplares similares